Search

everythinglearnresearchcommunity

for

Search:↓

Regenerative medicine may help reduce radiotherapy side effects like skin cancer, fibrosis, pain, and hair loss.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Vijaya successfully fought stage 2A breast cancer with surgery, chemotherapy, radiotherapy, and hormone therapy, while advocating for support groups.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Cancer prevention has progressed with successful drugs and vaccines, but challenges remain in understanding genetic changes and improving strategies.

Cancer prevention is crucial, with a focus on research and improved screening methods.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Radiotherapy can cause skin fibrosis, which is often overlooked and needs better treatment and evaluation.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Chemoprevention is rarely used due to concerns about risks, side effects, and lack of clear guidelines.

Scalp cooling therapy is costly and often not covered by insurance, limiting access for low-income patients.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Angelica sinensis and Tetrapanax papyrifer are common in Taiwanese TCM for lactation, with potential anticancer benefits.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

Endoscopic-assisted surgery leads to higher patient satisfaction in breast reconstruction.

People undergoing chemotherapy need better support and information to cope with hair loss.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Hair loss from cancer treatment is very distressing for women due to its impact on self-image and social stigma.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Targeting colon cancer stem cells might lead to better treatment results.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.